My Portfolio

Grail Inc GRAL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 6:40 PM EDT

60.21

-0.92 (-1.50%)

Volume

13,101

61.13

+1.23 (+2.05%)

Volume

779,563

52 week range

29.95 - 118.84

Open59.90
Day High61.34
Day Low56.70
Prev Close59.90
52 Week High118.84
52 Week High Date01/22/26
52 Week Low29.95
52 Week Low Date08/20/25

Latest On Grail Inc

Stocks making the biggest moves midday: Amazon, Shopify, Grail, Walmart & moreFebruary 20, 2026CNBC.com
Cramer's Stop Trading: GrailFebruary 20, 2026CNBC.com
Stocks making big moves premarket: Grail, Blue Owl Capital, OpendoorFebruary 20, 2026CNBC.com
Tuesday's biggest analyst calls: Nvidia, Apple, Southwest, Citi, Chevron, Shopify, Toast & moreFebruary 17, 2026CNBC.com
Odds of these speculative stocks making you money seems very slim: Jim CramerOctober 22, 2025CNBC.com
Lightning Round: I 'like' Innodata, says Jim CramerOctober 21, 2025CNBC.com
Cramer: I see a brewing risk to market rally — and it's not rising trade tensionsOctober 12, 2025CNBC.com

Key Stats

Market Cap2.623B
Shares Out42.92M
10 Day Average Volume1.03M
Dividend-
Dividend Yield-
Beta-

Latest On Grail Inc

Stocks making the biggest moves midday: Amazon, Shopify, Grail, Walmart & moreFebruary 20, 2026CNBC.com
Cramer's Stop Trading: GrailFebruary 20, 2026CNBC.com
Stocks making big moves premarket: Grail, Blue Owl Capital, OpendoorFebruary 20, 2026CNBC.com
Tuesday's biggest analyst calls: Nvidia, Apple, Southwest, Citi, Chevron, Shopify, Toast & moreFebruary 17, 2026CNBC.com
Odds of these speculative stocks making you money seems very slim: Jim CramerOctober 22, 2025CNBC.com
Lightning Round: I 'like' Innodata, says Jim CramerOctober 21, 2025CNBC.com
Cramer: I see a brewing risk to market rally — and it's not rising trade tensionsOctober 12, 2025CNBC.com

KEY STATS

Open59.90
Day High61.34
Day Low56.70
Prev Close59.90
52 Week High118.84
52 Week High Date01/22/26
52 Week Low29.95
52 Week Low Date08/20/25
Market Cap2.623B
Shares Out42.92M
10 Day Average Volume1.03M
Dividend-
Dividend Yield-
Beta-

RATIOS/PROFITABILITY

EPS (TTM)-10.37
P/E (TTM)-5.89
Fwd P/E (NTM)-5.47
EBITDA (TTM)-360.462M
ROE (TTM)-16.09%
Revenue (TTM)156.12M
Gross Margin (TTM)49.28%
Net Margin (TTM)-253.22%
Debt To Equity (MRQ)-

EVENTS

Earnings Date08/10/2026(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Piper Sandler Remains a Hold on GRAIL Inc (GRAL)June 2, 2026TipRanks
Grail assumed with a Peer Perform at Wolfe ResearchJune 1, 2026TipRanks
GRAIL Names Joshua Ofman CEO, Enhances Leadership CompensationJune 1, 2026TipRanks
Grail falls -18.4%June 1, 2026TipRanks
Canaccord Genuity Keeps Their Buy Rating on GRAIL Inc (GRAL)June 1, 2026TipRanks

Profile

Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including...

Gregory Summe

Independent Chairman of the Board

Joshua Ofman M.D.

Chief Executive Officer, Director

Aaron Freidin

Chief Financial Officer

Address

1525 O'brien Drive

Menlo Park, CA

94025

United States

https://grail.com/